Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan;42(1):147-156.
doi: 10.1007/s40264-018-0763-y.

Detecting Adverse Drug Events with Rapidly Trained Classification Models

Affiliations

Detecting Adverse Drug Events with Rapidly Trained Classification Models

Alec B Chapman et al. Drug Saf. 2019 Jan.

Abstract

Introduction: Identifying occurrences of medication side effects and adverse drug events (ADEs) is an important and challenging task because they are frequently only mentioned in clinical narrative and are not formally reported.

Methods: We developed a natural language processing (NLP) system that aims to identify mentions of symptoms and drugs in clinical notes and label the relationship between the mentions as indications or ADEs. The system leverages an existing word embeddings model with induced word clusters for dimensionality reduction. It employs a conditional random field (CRF) model for named entity recognition (NER) and a random forest model for relation extraction (RE).

Results: Final performance of each model was evaluated separately and then combined on a manually annotated evaluation set. The micro-averaged F1 score was 80.9% for NER, 88.1% for RE, and 61.2% for the integrated systems. Outputs from our systems were submitted to the NLP Challenges for Detecting Medication and Adverse Drug Events from Electronic Health Records (MADE 1.0) competition (Yu et al. in http://bio-nlp.org/index.php/projects/39-nlp-challenges , 2018). System performance was evaluated in three tasks (NER, RE, and complete system) with multiple teams submitting output from their systems for each task. Our RE system placed first in Task 2 of the challenge and our integrated system achieved third place in Task 3.

Conclusion: Adding to the growing number of publications that utilize NLP to detect occurrences of ADEs, our study illustrates the benefits of employing innovative feature engineering.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

Olga V. Patterson reports grants from National Heart, Lung, and Blood Institute, Department of Defense, Amgen Inc., Anolinx LLC, Genentech Inc., Gilead Sciences Inc., Merck & Co., Inc., Novartis International AG, and PAREXEL International Corporation outside the submitted work. Scott L. DuVall reports grants from National Heart, Lung, and Blood Institute during the conduct of the study; and grants from AbbVie Inc., Amgen Inc., Anolinx LLC, Astellas Pharma Inc., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim International GmbH, F. Hoffman-La Roche Ltd, Genentech Inc., Genomic Health, Inc., Gilead Sciences Inc., GlaxoSmithKline PLC, HITEKS Solutions Inc., Innocrin Pharmaceuticals Inc., Kantar Health, LexisNexis Risk Solutions, Merck & Co., Inc., Mylan Specialty LP, Myriad Genetics, Inc., Northrop Grumman Information Systems, Novartis International AG, PAREXEL International Corporation, and Shire PLC outside the submitted work. Alec B. Chapman, Kelly S. Peterson and Patrick R. Alba report no conflicts of interest that are directly relevant to the content of the reported study.

Ethical Approval

The study has been approved by the University of Utah Institutional Review Board.

References

    1. Yu H, Jagannatha AN, Liu F, Liu W. NLP Challenges for detecting medication and adverse drug events from electronic health records. 2018. http://bio-nlp.org/index.php/projects/39-nlp-challenges. Accessed 5 Dec 2018.
    1. World Health Organization. WHO|Pharmacovigilance [Internet]. WHO. World Health Organization; 2015. http://www.who.int/medicines/areas/quality_safety/safety_efficacy/pharmv.... Accessed 11 Sept 2018.
    1. Alatawi YM, Hansen RA. Empirical estimation of under-reporting in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS). Expert Opin Drug Saf [Internet]. 2017;16(7):761–7. http://www.ncbi.nlm.nih.gov/pubmed/28447485. Accessed 30 Jun 2018. - PubMed
    1. Vilar S, Harpaz R, Santana L, Uriarte E, Friedman C. Enhancing adverse drug event detection in electronic health records using molecular structure similarity: application to pancreatitis. PLoS One. 2012;7(7):e41471. http://www.ncbi.nlm.nih.gov/pubmed/22911794. - PMC - PubMed
    1. Nadkarni PM. Drug safety surveillance using de-identified EMR and claims data: issues and challenges. J Am Med Inf Assoc. 2010;17(6):671–4. http://www.ncbi.nlm.nih.gov/pubmed/20962129. - PMC - PubMed

Publication types

MeSH terms